Bluebook
Diagnostics & Tools January 2022
2022 - January: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- PreventionGenetics was acquired by Exact Sciences for $190mm
- Sema4 has agreed to acquire GeneDx for approximately $620mm
- Freenome received $290mm in a round of funding from The Roche Venture Fund